Arthritis Research UK is the resource for anyone looking for the latest news in the fight against arthritis. We’re providing answers today and tomorrow toward a future free from arthritis.
A maximum of 200 results have been returned
An Arthritis Research UK-backed study has demonstrated the benefits of a new iPad app that helps young people with juvenile idiopathic arthritis to describe their pain.
Find out more
A real-world study has demonstrated the similar levels of safety and efficacy provided by the biosimilar version of infliximab compared to the reference product in the treatment of rheumatic diseases.
New one-year clinical trial results have demonstrated the sustained efficacy the drug secukinumab can provide in the treatment of ankylosing spondylitis patients.
A new study has shown that subcutaneous tocilizumab can offer similar efficacy to the intravenous formulation in the treatment of rheumatoid arthritis.
NICE has published final guidance recommending ustekinumab, also known as Stelara, for the treatment of psoriatic arthritis within the NHS.
A study has identified risk factors for serious infections in patients with rheumatoid arthritis treated with abatacept, including old age and a past history of infections.
A new US population-based study has indicated that cardiovascular disease risk is higher in ankylosing spondylitis patients than is currently assumed.
People with knee osteoarthritis experience pain more intensely when it is accompanied by poor sleep and negative attitudes, according to research.
A world-first vaccine-style therapeutic approach to treat rheumatoid arthritis has been developed by Australian researchers.
A new study has indicated that dosage tapering is potentially suitable for some, though not all, ankylosing spondylitis patients being treated with etanercept.